Mettler-Toledo International (NYSE:MTD) Price Target Cut to $1,125.00 by Analysts at Wells Fargo & Company

Mettler-Toledo International (NYSE:MTD) had its target price decreased by equities researchers at Wells Fargo & Company from $1,400.00 to $1,125.00 in a research note issued to investors on Thursday,Benzinga reports. The firm currently has an “equal weight” rating on the medical instruments supplier’s stock. Wells Fargo & Company‘s price objective would indicate a potential upside of 11.43% from the company’s previous close.

A number of other equities research analysts have also weighed in on MTD. Citigroup upgraded Mettler-Toledo International from a “neutral” rating to a “buy” rating and set a $1,400.00 price objective on the stock in a research report on Monday, April 7th. Evercore ISI boosted their target price on shares of Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the company an “outperform” rating in a report on Monday, February 10th. Finally, Robert W. Baird raised their price objective on shares of Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the company a “neutral” rating in a research note on Monday, February 10th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and four have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $1,346.13.

Mettler-Toledo International Trading Down 0.7 %

NYSE MTD traded down $7.02 during trading hours on Thursday, hitting $1,009.63. The company’s stock had a trading volume of 107,166 shares, compared to its average volume of 140,196. The company has a market capitalization of $21.04 billion, a PE ratio of 24.98, a price-to-earnings-growth ratio of 3.30 and a beta of 1.28. Mettler-Toledo International has a 52 week low of $946.69 and a 52 week high of $1,546.93. The company’s 50-day simple moving average is $1,198.65 and its two-hundred day simple moving average is $1,268.28.

Mettler-Toledo International (NYSE:MTD) last posted its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, topping the consensus estimate of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. Research analysts anticipate that Mettler-Toledo International will post 42.71 EPS for the current fiscal year.

Insider Activity

In other Mettler-Toledo International news, insider Gerry Keller sold 600 shares of Mettler-Toledo International stock in a transaction on Monday, February 10th. The shares were sold at an average price of $1,351.34, for a total value of $810,804.00. Following the completion of the transaction, the insider now directly owns 6 shares of the company’s stock, valued at $8,108.04. This trade represents a 99.01 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Christian Magloth sold 790 shares of the company’s stock in a transaction dated Monday, February 24th. The shares were sold at an average price of $1,313.69, for a total transaction of $1,037,815.10. Following the sale, the insider now owns 734 shares in the company, valued at $964,248.46. This represents a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 1.94% of the company’s stock.

Institutional Trading of Mettler-Toledo International

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in MTD. Farther Finance Advisors LLC boosted its holdings in Mettler-Toledo International by 14.3% during the 4th quarter. Farther Finance Advisors LLC now owns 64 shares of the medical instruments supplier’s stock valued at $78,000 after acquiring an additional 8 shares during the period. M3 Advisory Group LLC lifted its holdings in shares of Mettler-Toledo International by 5.8% during the 4th quarter. M3 Advisory Group LLC now owns 165 shares of the medical instruments supplier’s stock valued at $202,000 after purchasing an additional 9 shares during the last quarter. Apollon Wealth Management LLC grew its stake in Mettler-Toledo International by 2.5% during the 4th quarter. Apollon Wealth Management LLC now owns 368 shares of the medical instruments supplier’s stock worth $451,000 after buying an additional 9 shares during the last quarter. Steward Partners Investment Advisory LLC boosted its holdings in Mettler-Toledo International by 3.0% in the fourth quarter. Steward Partners Investment Advisory LLC now owns 306 shares of the medical instruments supplier’s stock worth $374,000 after acquiring an additional 9 shares in the last quarter. Finally, Atlantic Union Bankshares Corp increased its holdings in shares of Mettler-Toledo International by 0.5% during the fourth quarter. Atlantic Union Bankshares Corp now owns 2,083 shares of the medical instruments supplier’s stock valued at $2,549,000 after acquiring an additional 10 shares in the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

About Mettler-Toledo International

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.